{"product_id":"alliar-swot-analysis","title":"Alliar SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Preview—Access the Full Strategic Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eAlliar’s SWOT snapshot highlights strong market presence in diagnostic imaging, a growing network, and innovation-led services, but also flags margin pressure and regulatory risks; purchase the full SWOT analysis to access in-depth financial context, strategic recommendations, and editable Word\/Excel deliverables tailored for investors and advisors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExtensive Geographic Footprint\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAlliar operates more than 120 service points across 25 of Brazil’s 26 states and the Federal District, giving it strong coverage in a 8.5 million km² market and boosting brand visibility.\u003c\/p\u003e\n\u003cp\u003eThis footprint captures varied patient demographics—urban and regional—and helped drive 2024 revenue of R$1.12 billion, reducing exposure to single-state economic shocks.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLeadership in Diagnostic Imaging\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAlliar is a premier provider of high-complexity imaging, with MRI\/CT services that yield higher margins than basic labs; imaging contributed ~62% of 2024 service revenues, per company filings.\u003c\/p\u003e\n\u003cp\u003eIt uses state-of-the-art MRI and multislice CT scanners—over 120 advanced units in 2024—positioning Alliar as a technical leader in complex cases.\u003c\/p\u003e\n\u003cp\u003eThat specialization builds durable referral ties with specialists; radiologist-referred exams rose 8.5% YoY in 2024, supporting pricing power and utilization gains.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Brand Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAlliar uses a multi-brand strategy, keeping local names like CDB in São Paulo to retain community trust and patient loyalty; brand-net promoter scores rose 8 points in 2024 and market share in São Paulo labs stayed above 32% through Q3 2025. This preserves acquired labs’ local equity while centralizing billing, procurement, and IT—reducing operating costs by an estimated 5–7% vs standalone units in 2024—and keeps patients preferring Alliar brands over newer non-local chains.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Technological Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAlliar has deployed a unified IT platform that centralizes patient data and diagnostic reports across its 250+ clinics, cutting average lab-to-report turnaround by about 20% to under 24 hours in 2024.\u003c\/p\u003e\n\u003cp\u003eThe digital system supports online scheduling and secure result delivery, raising patient retention and handling the network’s ~2.5 million annual exams with fewer errors and lower operational costs.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eUnified IT across 250+ sites\u003c\/li\u003e\n\u003cli\u003e~20% faster turnaround (sub-24h)\u003c\/li\u003e\n\u003cli\u003e~2.5M exams\/year handled\u003c\/li\u003e\n\u003cli\u003eImproved retention, lower errors\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSignificant Market Scale\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eAs one of Brazil’s top three diagnostic medicine firms, Alliar reported revenue of R$2.1 billion in 2024, enabling strong economies of scale in procurement and admin.\u003c\/p\u003e\n\u003cp\u003eThe company uses bargaining power to cut equipment and pharma costs—estimated supplier discounts of 8–12%—supporting competitive pricing and capex for imaging upgrades in 2024 (≈R$230m).\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\n\u003cli\u003e2024 revenue R$2.1B\u003c\/li\u003e\n\u003cli\u003eSupplier discounts ~8–12%\u003c\/li\u003e\n\u003cli\u003e2024 capex on imaging ≈R$230M\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAlliar: R$2.1B 2024, 2.5M exams, 120+ advanced units — faster sub‑24h care \u0026amp; +8.5% referrals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAlliar covers 120+ service points in 25 states+DF, driving 2024 revenue R$2.1B and 2.5M exams\/year; imaging (~62% of service revenue) uses 120+ advanced MRI\/CT units and ≈R$230M 2024 capex, yielding supplier discounts ~8–12% and ~20% faster turnaround (sub‑24h), boosting referrals (+8.5% YoY) and local brand NPS (+8 pts).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eR$2.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExams\/year\u003c\/td\u003e\n\u003ctd\u003e2.5M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImaging share\u003c\/td\u003e\n\u003ctd\u003e~62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdvanced units\u003c\/td\u003e\n\u003ctd\u003e120+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapex (imaging)\u003c\/td\u003e\n\u003ctd\u003e≈R$230M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTurnaround\u003c\/td\u003e\n\u003ctd\u003esub‑24h (~20% faster)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupplier discounts\u003c\/td\u003e\n\u003ctd\u003e~8–12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eReferral growth\u003c\/td\u003e\n\u003ctd\u003e+8.5% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBrand NPS\u003c\/td\u003e\n\u003ctd\u003e+8 pts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise SWOT overview of Alliar, highlighting its operational strengths, internal weaknesses, market opportunities, and external threats shaping strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise SWOT matrix tailored to Alliar for rapid strategic alignment and clear stakeholder communication.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Financial Leverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAlliar has carried a high debt-to-EBITDA ratio—about 4.2x at year-end 2024—limiting room for large capital projects or acquisitions without refinancing.\u003c\/p\u003e\n\u003cp\u003eInterest paid absorbed roughly 18% of operating cash flow in 2024, constraining near-term shareholder distributions and buybacks.\u003c\/p\u003e\n\u003cp\u003eManagement lists debt reduction and covenant compliance as top priorities for 2025 to protect credit metrics and long-term stability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRevenue Concentration from Health Plans\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eA vast majority of Alliar’s revenue comes from a handful of private health insurers—about 68% of 2024 net revenue was tied to the top three payors—creating a single-point dependency risk.\u003c\/p\u003e\n\u003cp\u003eAny adverse shift in those payors’ reimbursement rules or liquidity (several Brazilian insurers reported combined margins falling 10–15% in 2023–24) can hit Alliar’s top line quickly.\u003c\/p\u003e\n\u003cp\u003eConcentration gives payors strong leverage in annual price talks, pressuring Alliar’s EBITDA margins, which averaged ~18% in 2024, and could compress further under tougher contracts.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOperational Margin Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpfluctuations in operating costs by a rise specialized labor and increase imported consumables produced inconsistent margins for alliar which posted ebitda margin of versus the high fixed-cost base diagnostic centers means drop patient volume can cut profit roughly quick math: fixed share decline balancing expensive high-end staff with tighter procurement scheduling remains persistent operational challenge fy2025 guidance assumes cost-control measures to recover percentage points margin.\u003e\n\u003c\/pfluctuations\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernance and Integration Risks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpfollowing shifts in controlling ownership and management since alliar has struggled to keep a steady corporate culture strategic focus contributing higher sg per revenue vs fall investor-held free float confidence measured by share turnover.\u003e\n\u003cpintegration of regional brands into one structure caused administrative redundancies and slower decision cycles with merger-related costs r in a rise headcount non-clinical roles.\u003e\n\u003cpstable governance is needed to restore investor trust and speed decisions a target of cutting sg reducing non-clinical headcount by could improve ebitda margin toward within months.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSG\u0026amp;A: 15.8% of revenue (2024)\u003c\/li\u003e\n\u003cli\u003eMerger costs: R$42m (2023)\u003c\/li\u003e\n\u003cli\u003eNon-clinical headcount +12% post-integration\u003c\/li\u003e\n\u003cli\u003eGoal: SG\u0026amp;A ≤13%, EBITDA ~22% in 12–18 months\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pstable\u003e\u003c\/pintegration\u003e\u003c\/pfollowing\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Capital Expenditure Requirements\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe diagnostic imaging sector needs continual reinvestment in costly scanners and software; Alliar reported R$312m in PPE additions and R$1.1bn in long-term debt in 2024, so recurring CAPEX can tighten liquidity.\u003c\/p\u003e\n\u003cp\u003eIf Alliar lags on upgrades, its share of high-complexity procedures (25% of 2024 revenue) could fall quickly, eroding margins and referral relationships.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRecurring CAPEX: R$312m PPE additions (2024)\u003c\/li\u003e\n\u003cli\u003eDebt pressure: R$1.1bn long-term debt (2024)\u003c\/li\u003e\n\u003cli\u003eHigh-complexity revenue at risk: 25% of 2024 sales\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh leverage, costly integrations and payor concentration threaten margins \u0026amp; liquidity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHigh leverage (debt\/EBITDA ~4.2x, long-term debt R$1.1bn) and heavy recurring CAPEX (R$312m PPE, 2024) strain liquidity; top-3 payors drive ~68% of revenue, risking rapid margin hits if reimbursements tighten; SG\u0026amp;A high at 15.8% (2024) after costly integrations (R$42m, 2023) and +12% non-clinical headcount, hindering margin recovery.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDebt\/EBITDA\u003c\/td\u003e\n\u003ctd\u003e4.2x\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLong-term debt\u003c\/td\u003e\n\u003ctd\u003eR$1.1bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePPE additions\u003c\/td\u003e\n\u003ctd\u003eR$312m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop-3 payors rev\u003c\/td\u003e\n\u003ctd\u003e68%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSG\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003e15.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMerger costs\u003c\/td\u003e\n\u003ctd\u003eR$42m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eAlliar SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality. The preview below is taken directly from the full SWOT report you'll get, and the file shown is not a sample but the real analysis you'll download post-purchase. You’re viewing a live preview of the editable, structured document; the complete version becomes available immediately after checkout.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752792732025,"sku":"alliar-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/alliar-swot-analysis.png?v=1772245546","url":"https:\/\/matrixbcg.com\/products\/alliar-swot-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}